Latest filing published 28 Mar 2024 for InnoCan Pharma Corporation.
No signal scores available.
Ralph Bossino discloses dealings in InnoCan Pharma Corporation to SEDI. In total, 3 filings cover trades dated from 25 September 2019 to 25 March 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 28 March 2024 with an option exercise in InnoCan Pharma Corporation. Typically, a trade is published a median of 3 days after it takes place. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations